Tracon Pharmaceuticalsincwas A Biopharmaceutical Company Based In San Diegocaliforniadedicated To Developing Targeted Therapeutics For Cancer And Fibrotic Diseaseswith A Strong Focus On Oncologythe Company Specialized In Creating Novel Therapies For Unmet Medical Needsparticularly In Advanced Cancersand Emphasized Orphan Drug Designations To Facilitate Regulatory Processestracon Collaborated With Institutions Like The National Cancer Institute And Partnered With Biopharmaceutical Firms Such As 3D Medicines And I Mab Biopharma Tracon S Clinical Stage Products Included Envasarc For Refractory Soft Tissue Sarcomayh001 Targeting Various Cancersand Trc102 For Mesothelioma And Lung Cancerthe Company Also Worked On Bispecific Antibodies For Hematologic Malignancies And Solid Tumorsin November 2024Tracon S Stockholders Approved A Plan For Liquidation And Dissolutionmarking The End Of Its Operations
No conferences found for this company.
| Company Name | Tracon Pharmaceuticals Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
